---
title: CONTINUUS Pharmaceuticals vs Winkem Labs Pvt. Ltd.
slug_a: continuuspharma
slug_b: winkemlabs
site: cdmo
review_signal_gate: closed
canonical_path: /compare/continuuspharma/winkemlabs
---

# CONTINUUS Pharmaceuticals vs Winkem Labs Pvt. Ltd.

Side-by-side profile data from each company listing on this directory.

## CONTINUUS Pharmaceuticals

- Profile: [/companies/continuuspharma](/companies/continuuspharma)

CONTINUUS Pharmaceuticals — CONTINUUS Pharmaceuticals specializes in Integrated Continuous Manufacturing (ICM)—a transformative approach that replaces traditional batch processes with end-to-end continuous flows for active pharmaceutical ingredients (APIs) and final dosage forms.

Services: 6. Modalities: 1. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (6).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Flow Chemistry & Continuous Manufacturing
- Process Development
- Formulation Development
- CMC Analytical Development

### Modalities

- Small Molecule

### Development capabilities

- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Flow Chemistry

## Winkem Labs Pvt. Ltd.

- Profile: [/companies/winkemlabs](/companies/winkemlabs)

Winkem Labs Pvt. Ltd. — Contract development and manufacturing organization (CDMO) offering complex chemical synthesis, process development, API manufacturing, and supply services for pharmaceutical clients globally.

Services: 7. Modalities: 1. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (7).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Process Development
- Technology Transfer
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Max bioreactor: Mid-scale clinical (≤2,000 L)
- Stainless Steel
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI
- Cryogenic (−80 °C)